Hospi Closes Funding Round with Investments from Post-Acute Industry Leaders

Oct 18, 2023

Summary

Medical device company Hospi Corporation has successfully closed its Series B-1 funding round, securing investments from industry leaders Tom Maxwell, Bryan Wolfe, and Matt McMurphy. The funding round will support the development and expansion of the company's flagship product, the Macy Catheter, which is used in post-acute care settings to administer fluids and medications when the oral route is compromised.

Tom Maxwell, Chairman and Co-Founder of Maxwell Healthcare Associates, cited the value of quickly palliating patients in their chosen setting as his reason for investing in Hospi. Bryan Wolfe, former CEO of Traditions Health, joined Hospi's Board of Directors to contribute to providing pain relief and discomfort solutions for seriously ill patients. Matt McMurphy, healthcare investor and President/CEO of Reliant at Home, brings his operational expertise to help enhance patient comfort and reduce costs.

Hospi Corporation is dedicated to creating practical medical devices that enhance the quality of life for patients and caregivers. The Macy Catheter is a vital tool for post-acute care programs such as home health, hospice, and palliative care, and is designed to administer medications even in non-sterile environments.

Hospi Corporation's CEO, Igal Ladabaum, expressed enthusiasm for the new investors, emphasizing their commitment to bringing the benefits of the Macy Catheter to more patients and caregivers. The company is focused on scaling its medication administration technology and advancing its mission to enhance patient comfort and wellbeing.

For more information about Hospi Corporation and the Macy Catheter, visit their respective websites.

Hospi Corporation, known for the Macy Catheter, announces the successful close of its final Series B-1 funding round with investments from industry leaders including Tom Maxwell, Bryan Wolfe, and Matt McMurphy. Wolfe joins Hospi’s Board of Directors, while McMurphy and Maxwell enlist as advisor

San Mateo, United States - October 18, 2023 /PressCable/ —

Hospi Corporation, the patient-centric medical device company known for the Macy Catheter, announces the successful close of its Series B-1 funding round.

New investors include industry leaders Tom Maxwell, Bryan Wolfe, and Matt McMurphy. Their involvement validates the potential of the Macy Catheter to enhance post-acute care nationwide.

Tom Maxwell is well-situated to evaluate the impact and contribution that Hospi can make to post-acute healthcare from his perch as Chairman and Co-Founder of Maxwell Healthcare Associates (a business consulting firm specialized in home health and hospice), as an Operating Partner with the Vistria Group, as Non-Executive Chairman of the Board at Medalogix, as a strategic advisor and investor at Trella Health, and as a board member of several home health and hospice focused entities. Tom invested in Hospi via his role as Co-Chief Executive Officer at Maxwell Investment Partners along with his business partner Jennifer Maxwell.

"We invested in Hospi because I appreciate the value of being able to quickly palliate patients in the setting of their choice," said Tom Maxwell. "I trust the team, I like the economics, and, as in all our investments, we believe we can make a difference; we intend to roll up our sleeves to help."

Bryan Wolfe-who co-founded and built national hospice and home health provider Traditions Health from a single office in College Station, Texas in 2008 to over 75 offices across 14 states as its CEO prior to his retirement in 2021-is representing the new investors on Hospi's Board of Directors.

Bryan said, "I decided to invest and serve on Hospi's Board because providing seriously ill patients and their families a solution to pain relief and discomfort associated with end of life care is very important to me. No one should have to die in pain or discomfort. I think every hospice in the country will eventually adopt the Macy Catheter."

Matt McMurphy is a healthcare investor with direct operational experience across various executive-level functions within the healthcare industry. He is President/CEO of Reliant at Home in Texas, an active board member at Acacia Health in California, founder and partner at Lakewood Healthcare Capital, and was formerly Vice President of Strategy and General Counsel of Encompass Home Health & Hospice. The diversity of McMurphy’s expertise makes him an invaluable source of insight as Hospi continues on its mission to enhance patient comfort and wellbeing, ease caregiver burden, and reduce cost.

Igal Ladabaum, Hospi's co-founder and CEO, said "We are delighted to welcome post-acute leaders Tom, Bryan, and Matt to the Hospi family, and are humbled to have been able to attract contributors of their caliber. We look forward to working together to bring the benefits of our medication administration technology to many more patients and caregivers. The world deserves this technology at scale."

About Hospi Corporation

Hospi Corporation was founded to innovate practical medical devices that improve quality of life for both patients and their caregivers.

For more information, visit https://www.hospicorp.com/.

About the Macy Catheter

Hospi Corporation’s flagship product, the Macy Catheter, is used by leading post-acute programs in the United States (i.e. home health, hospice, palliative care, and skilled nursing) to administer fluids and medications when the oral route is compromised- in any setting and without sterile technique.

For more information, visit https://www.macycatheter.com/.

For Media Inquiries

Contact Molly Seaman at [email protected] or 510-270-4355 x10.

Contact Info:
Name: Hospi Clinical Team
Email: Send Email
Organization: Hospi Corporation
Address: 1650 S. Amphlett Blvd Suite 201, San Mateo, CA 94402, United States
Phone: +1-888-509-3732
Website: https://www.macycatheter.com/

Source: PressCable

Release ID: 89110789

If there are any errors, inconsistencies, or queries arising from the content contained within this press release that require attention or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting [email protected]. Our reliable team will be available to promptly respond within 8 hours, taking proactive measures to rectify any identified issues or providing guidance on the removal process. Ensuring accurate and dependable information is our top priority.

More News

Pretty Skin & Lamelin welcomes EGY Aesthetic and Medical Spa as authorized reseller

Sep 26, 2026

Pretty Skin & Lamelin welcomes EGY Aesthetic and Medical Spa as authorized reseller

PRETTY Skin & Lamelin Philippines has welcomed EGY Aesthetic and Medical Spa to its growing network of authorized resellers, expanding access to Korean skincare products in the country. The partnership was formalized through a Reseller Agreement signed Aug. 23 between Pharmline Medforce Inc., the official Philippine distributor of Pretty Skin & Lamelin, and EGY Aesthetic and Medical Spa, owned by Emmiebeth Yap. The collaboration aims to bring science-backed Korean skincare products closer to Filipino consumers through aesthetic, beauty and wellness establishments that also provide personalized skin care services. As part of the agreement, EGY Aesthetic and Medical Spa will gain access to Pretty Skin and Lamelin's portfolio of Korean skincare products, along with product education, training materials, marketing support and regular brand and product updates from Pharmline Medforce. The partnership also emphasizes proper product representation and customer education, with both companies seeking to provide consumers with more informed choices when it comes to skincare and skin wellness. For Pretty Skin & Lamelin Philippines, the agreement with EGY is part of its efforts to build a nationwide network of dermatologists, aesthetic doctors, clinics, beauty and wellness centers, distribution partners and authorized resellers. "We are delighted to welcome Ms. Emmiebeth Yap and EGY Aesthetic and Medical Spa into the Pretty Skin & Lamelin family. Every new partnership allows us to reach another community and gives us another opportunity to build greater awareness, education and confidence in skincare," said Catherine R. Andres, CEO of Pretty Skin & Lamelin Philippines. The agreement was signed by Andres on behalf of Pharmline Medforce and Yap as owner of EGY Aesthetic and Medical Spa. The companies said they look forward to bringing Korean skincare products, education and personalized beauty experiences to more Filipino consumers through the new partnership.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.